Serving as a powerful complement and extension to conventional methods, the combined analysis of SHOX2 and RASSF1A methylation could enhance the accuracy of lung cancer diagnosis, offering satisfactory sensitivity and specificity. This evidence concerns the gene SHOX2 and lung carcinoma.